Analysts Set Kailera Therapeutics, Inc. (NASDAQ:KLRA) PT at $42.75
Kailera Therapeutics, Inc. (NASDAQ:KLRA – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eight analysts that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and one has given […]
21 Sep 06:28 · The Cerbat Gem